SynthesisHealth technology assessment (Winchester, England)2020

Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.

Sarah Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.